Trending...
- FlyBright Pilot Academy Partners with Allegiant Air to Address the Pilot Shortage
- BEPeterson Building Engineering Partnerships
- NaturismRE, ANF, and GNA Stand United for Naturist Rights in Australia – A Call for Global Support
~ Q'Apel Medical (Q'Apel), a leading medical device company, has recently announced the receipt of CE mark certification for its innovative Armadillo SelectFlex™ Neurovascular Access System. This groundbreaking 7F system, equipped with patented SelectFlex™ Technology, is specifically designed to simplify neurovascular interventions.
According to Pascal Jabbour, MD, FAANS, FACS, FAHA, The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology at Thomas Jefferson University Hospital in Philadelphia, PA, navigating the complex anatomy of the neurovasculature can be extremely challenging. While flexible access catheters are necessary for maneuvering through tight twists and turns, they often lack the necessary support and stability for device delivery once in position. However, with Armadillo's one-and-done solution, physicians can easily transform the catheter from highly trackable to highly supportive as needed throughout the procedure with just a simple injection or withdrawal of 0.2cc of saline.
More on The PennZone
The Armadillo Neurovascular Access System with SelectFlex™ Technology offers physicians the versatility they need to confidently tackle a wide range of neurovascular interventions. Its low-profile 7F catheter allows for a biaxial approach regardless of access site, accelerating delicate procedures and eliminating the complexity and cost associated with conventional tri-axial configurations.
Jodie Fam, CEO of Q'Apel Medical, believes that their new system addresses the limitations of current neurovascular access catheters. She states that it provides a unique option for hospitals to standardize device usage while reducing inventory constraints and cost per procedure. Fam also expresses her gratitude towards their team for achieving this critical milestone and looks forward to expanding their international portfolio by delivering this meaningful solution to the European market and beyond in the coming months.
With its revolutionary technology and potential cost-saving benefits for hospitals, Q'Apel's Armadillo SelectFlex™ Neurovascular Access System is set to revolutionize neurovascular interventions and improve patient outcomes. The company's success in the U.S. market has paved the way for its expansion into the international market, bringing this innovative solution to more physicians and patients in need.
According to Pascal Jabbour, MD, FAANS, FACS, FAHA, The Angela and Richard T. Clark Distinguished Professor of Neurological Surgery and Radiology at Thomas Jefferson University Hospital in Philadelphia, PA, navigating the complex anatomy of the neurovasculature can be extremely challenging. While flexible access catheters are necessary for maneuvering through tight twists and turns, they often lack the necessary support and stability for device delivery once in position. However, with Armadillo's one-and-done solution, physicians can easily transform the catheter from highly trackable to highly supportive as needed throughout the procedure with just a simple injection or withdrawal of 0.2cc of saline.
More on The PennZone
- Explore the "Magic of Rainbows" in the New Children's Book Series "Mila and Ally's STEMventures
- Relentless 2800 Challenge: A 40-Day Team Fitness Journey Launching for Lent 2025
- Super Locksmith In Tampa Florida
- Super Locksmith Saint Petersburg
- Exeter Smiles in Reading Enhances Orthodontic Care with DIBS AI Technology
The Armadillo Neurovascular Access System with SelectFlex™ Technology offers physicians the versatility they need to confidently tackle a wide range of neurovascular interventions. Its low-profile 7F catheter allows for a biaxial approach regardless of access site, accelerating delicate procedures and eliminating the complexity and cost associated with conventional tri-axial configurations.
Jodie Fam, CEO of Q'Apel Medical, believes that their new system addresses the limitations of current neurovascular access catheters. She states that it provides a unique option for hospitals to standardize device usage while reducing inventory constraints and cost per procedure. Fam also expresses her gratitude towards their team for achieving this critical milestone and looks forward to expanding their international portfolio by delivering this meaningful solution to the European market and beyond in the coming months.
With its revolutionary technology and potential cost-saving benefits for hospitals, Q'Apel's Armadillo SelectFlex™ Neurovascular Access System is set to revolutionize neurovascular interventions and improve patient outcomes. The company's success in the U.S. market has paved the way for its expansion into the international market, bringing this innovative solution to more physicians and patients in need.
Filed Under: Business
0 Comments
Latest on The PennZone
- Aterna AI Introduces Automated Investing Software for Entrepreneurs Focused on Reliable Growth
- Rutgers University Student Wins "New Jersey's Top Student Entrepreneur" in EO's Global Student Entrepreneur Awards
- VIP Vacations Named Winner Of The Knot Best Of Weddings 2025
- Angel's Awesome Puzzles Launches Educational Puzzle for Children with Autism & Learning Disorder
- Introducing Numbers and Shapes Flash Cards & Book: Engaging Learning Tools for Children with Autism
- Angel's Awesome Shea Butter Launches Organic, Sensory-Friendly Skincare Line for Kids
- Angel's Awesome Books Launches Positive Affirmation Journal for Kids with Autism Support
- Global Digital Currency & Wealth Management Leader; Breakout 388% FY2025 Revenue Growth Over $19.7 Million: Metalpha Technology (Stock Symbol: MATH)
- Breakaway Introduces New SAP Integration Agent for Enhanced Data Integration in GTN Platform
- InterMountain Opens Urban Inspired Aloft Sacramento Airport Natomas
- Popular Senior Housing Series Continues
- Kennedy Living Law Firm REPLIES to Introducing the American Federation Dollar. Notice to Agents is Notice to Principals; Notice to Principals is N
- MOBILion Systems to Present Advanced Proteomics Capabilities with New PAMAF Operating Mode at US HUPO 2025
- Cura HR's CEO, Lyssa Hansard, Featured in Forbes: Driving Meaningful Change in Pay Equity
- Zezgo Rent A Car has arrived In Cyprus to Improve Car Rental Options
- Meredith Thomas Returns as Master of Ceremonies for International Women's Day Gala for 2025
- Kim Estes Returns as Master of Ceremonies for International Women's Day Gala for 2025
- Andre Kay Honored with Black Excellence Award by the Florida Panthers
- Wide range of dental care products at upto 40% discounted prices | DentistryDeal.com
- NaturismRE, ANF, and GNA Stand United for Naturist Rights in Australia – A Call for Global Support